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a b s t r a c t
Background: New direct oral anticoagulants (DOACs) are commonly used in the management of atrial
ﬁbrillation and VTE. Currently, there is no strong evidence to support the current practice of routinely
repeating computed tomography (CT) head in anticoagulated patients within 24 hours after their ﬁrst
negative CT scan to assess for new and delayed intracranial hemorrhage (ICH). Our hypothesis is that the
vast majority will not have new CT scan ﬁndings of ICH and those who do would not require any further
intervention.
Methods: This is retrospective cohort study. IRB approval was obtained. Subjects included adults age ≥
18 taking DOACs who presented to our level III trauma center with conﬁrmed or suspected blunt head
trauma between August 2013 and October 2019 and received at least one head CT scans.
Results: 498 Patient encounters met inclusion criteria. Only 19 patients (3.8%) had positive traumatic ICH
on the initial CT head. Those had a higher ISS. 420 out of 479 initial negative CT encounters received a
second CT head. Only 2 (0.5%) had delayed positive second CT scan for ICH. 95%CI [0.06%, 1.7%] Patients
who developed a new ICH on the second CT head after an initial negative CT scan had a lower Glasgow Coma Scale (GCS) on presentation and a higher ISS. None of those patients required neurosurgical
intervention
Conclusion: Our data suggests that the risk of developing a new or delayed traumatic ICH for patients on
DOAC on a second CT head within 24 hours following an initial negative CT is very low and when present
did not require neurosurgical intervention and thus does not support routinely obtaining a repeat CT head
within 24 hours after a negative initial CT scan. Patients presenting with lower GCS and higher ISS had a
higher chance of having a delayed ICH.
© 2021 Elsevier Ltd. All rights reserved.

Background
Traumatic injury has become the ﬁfth leading cause of death in
the elderly population [1]. According to the National Trauma Data
Bank, in 2014, 39% of patients presenting with traumatic injuries
were over 55-year-old, and patients in this age range comprised
54% of all trauma related deaths [1]. Of trauma related deaths occurring in patients greater than 65 years of age, 46% are secondary
to falls [2]. A large percentage of these patients are on antithrombotic therapy, including anti platelet agents, warfarin, and Direct
Oral Anticoagulants (DOACs).
There is an ongoing debate regarding management of head
trauma in patients on antithrombotic therapy. Studies have demonstrated that patients on antithrombotic therapy have an in∗
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creased risk of intracranial hemorrhage (ICH), and a lower mechanism of injury may be necessary to cause hemorrhage [3]. EAST
Trauma guidelines recommend anticoagulated patients with supratherapeutic INR and normal initial CT Head remain in the hospital for observation for at least 24 hours (Level 3 data) but do not
give clear guidelines regarding need for repeat CT head or how to
manage anticoagulated patients when INR does not reﬂect anticoagulation status, as with DOACs [4]. Some centers manage these
patients with 24-hour observation, while others obtain a repeat CT
head in 12-24 hours prior to discharge. Studies have demonstrated
that a repeat CT head may not be necessary, and may not provide
beneﬁt beyond clinical observation, while utilizing extra resources
[5,6]. For instance, a multi-institutional prospective cohort study
including 859 patients demonstrated that incidence of delayed intracranial hemorrhage in patients with blunt head trauma on antiplatelet or anticoagulant therapy was low, and comparable to incidence in patient not on any antithrombotic therapies, suggesting
that routine repeat imaging is not necessary [7]. There is a paucity
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of data on the need for repeat CT head in patients speciﬁcally on
direct oral anticoagulants.
DOACs include direct factor Xa inhibitors Apixaban, Rivaroxaban, Edoxaban, and direct thrombin inhibitor Dabigatran. DOACs
have multiple beneﬁts over the classic vitamin K antagonist, warfarin, which has a narrow therapeutic window, long half-life, multiple interactions with foods and other pharmaceuticals, and requires weekly monitoring. DOACs have a shorter half-life and do
not require monitoring to ensure therapeutic range. On the other
hand, newly developed reversal agents for DOACs, including Idarucizumab, and Adnexanet, are costly and not uniformly available.
Studies have shown that patients with signiﬁcant trauma who are
on DOACs may have improved mortality and blood transfusion requirements compared to patients on warfarin [8]. As DOACs become increasingly utilized by the population it is imperative to investigate their impact on clinical course and management of head
trauma.
Elderly patients presenting with low-velocity head trauma including ground level falls while on anticoagulant therapy make up
a signiﬁcant portion of cases presenting to our trauma center. Current organization speciﬁc practice entails placing the patient in observation and obtaining a repeat CT head within 24 hours of initial imaging. This requires an increase in healthcare resource utilization with increasing costs and potentially an increase in hospital related adverse events and may also pose a burden to patients
and their families. We hypothesize that the vast majority of low
mechanism blunt head trauma patients on DOACs with no abnormal initial CT head ﬁndings will not have new delayed intracranial
bleeding and do not in fact beneﬁt from extended hospital stay
or repeat imaging. In order to assess the utility of repeat imaging
in this growing patient population, we undertook a retrospective
review of all consecutive head traumas patients on DOAC therapy
presenting to our institution.

less than 18 years of age or who were transferred outside of our
Health System.
Per our hospital protocol, patients on DOAC therapy who
present within 12 hours of suspected or conﬁrmed head trauma
were admitted for observation and received a timed repeat CT
head imaging 12 hours following the initial CT head scan. Thus,
patients presenting late (>12hours) after head trauma would not
require a repeat CT scan of the head if the initial one was negative.
The primary measure was the frequency of new or delayed
acute intracranial hemorrhage found on a second CT of the head.
Secondary measures included identiﬁcation of key patient factors
that may predict likelihood of developing new or delayed acute intracranial hemorrhage on repeat CT head imaging. Through chart
review, we identiﬁed key factors and demographic information including age, sex, traumatic mechanism, Glasgow Coma Scale (GCS),
Injury Severity Score (ISS), concurrent use of aspirin or clopidogrel,
and type of DOAC.
Numerical data is reported as mean (standard deviation), [median]. Categorical data is reported as frequency (percent). Continuous variables including age, GCS, ISS were analyzed using the
Wilcoxon Rank Sum Test. Fisher’s Exact Test was used to compare
sex and traumatic mechanism in patients with a negative versus
positive initial CT of the head, and used for sex, DOAC type and
traumatic mechanism in comparing patients second CT scan ﬁndings following an initial negative CT scan. Chi-Square test was used
to analyze DOAC type in patients with initial negative CT head versus initial positive CT head. An alpha value of p < .05 was used to
differentiate statistical signiﬁcance.
Results
The study included a total of 498 patient encounters for conﬁrmed or suspected blunt head trauma in adult patients on DOACs.
400 unique patients comprised all 498 encounters as 15.5% of patients presented more than once during the study period. Mean
age of patient encounters was 76 (SD 14) years. 277 were females
(55.6%) and 221 (44.4%) were males. Fall was the most common
mechanism of injury (96.9%) with most being low height or ground
level fall.
The ﬁrst CT scan of the head was negative in 479 of these encounters (96.2%). Of these patients encounters with a negative initial CT scan of the head, 59 patient encounters (12.3%) did not have
a repeat head CT scan and 420 patient encounters (87.7%) under-

Methods
Institutional Review Board approval was obtained for this retrospective study. A waiver of consent was obtained. A retrospective
chart review was performed that included all adult patients who
presented to our American College of Surgeons designated Level III
trauma center between August 2013 and October 2019 who had
either conﬁrmed or suspected blunt head trauma who were on a
DOAC (Apixaban, Rivaroxaban, or Dabigatran) and received at least
one CT head scan. Exclusion criteria included patients who were

Table 1
Comparison Results for Initial Negative CT Head versus Initial Positive CT Head

Age
Sex
DOAC

Mechanism

GCS
ISS
ASA
Clopidogrel

Female
Male
Apixaban
Dabigatran
Rivaroxaban
Assault
Fall
MVC
Struck∗ ∗

No
Yes
No
Yes

Negative First CT
(N=479)

Positive First CT
(N=19)

Comparison
P-value

75.8 (13.6), [79.0]
262 (54.7%)
217 (45.3%)
311 (64.9%)
33 (6.9%)
135 (28.2%)
6 (1.3%)
461 (96.2%)
7 (1.5%)
5 (1.0%)
14.9 (0.6), [15.0]
3.3 (3.2), [1.0]
—–
—–
—–
—–

80.1 (9.7), [82.0]
15 (78.9%)
4 (21.1%)
10 (52.6%)
1 (5.3%)
8 (42.1%)
0 (0.0%)
18 (94.7%)
1 (5.3%)
0 (0.0%)
14.8 (0.4), [15.0]
9.9 (6.5), [6.0]
11 (57.9%)
8 (42.1%)
18 (94.7%)
1 (5.3%)

0.240 (W)
0.058 (F)
0.420 (C)

0.529 (F)

0.106 (W)
<0.001 (W)
—–

∗

—–

Table 1: Comparison Results for patient encounters with initial negative CT of the head versus initial positive CT
scan of the head. Numerical data is given as Mean (Standard Deviation), [Median]. (W) = Wilcoxon Rank Sum Test.
(C) = Chi-Square Test. (F) = Fisher’s Exact Test. ∗ Statistically Signiﬁcant, P < 0.05. ∗ ∗ Head struck with hard object.
2
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Table 2
Comparison Results for Second Negative CT Head versus Second Positive CT Head Using only Patients with a Negative First
CT Result

Age
Sex
DOAC

Mechanism

GCS
ISS
ASA
Clopidogrel

Female
Male
Apixaban
Dabigatran
Rivaroxaban
Assault
Fall
MVC
Struck∗ ∗

No
Yes
No
Yes

Negative First CT/
Negative Second CT
(N=418)

Negative First CT/
Positive Second CT
(N=2)

75.4 (13.9), [79.0]
229 (54.8%)
189 (45.2%)
278 (66.5%)
29 (6.9%)
111 (26.6%)
3 (0.7%)
405 (96.9%)
5 (1.2%)
5 (1.2%)
14.9 (0.6), [15.0]
3.0 (3.1), [1.0]
—–
—–
—–
—–

61, 81, [71.0]
1 (50.0%)
1 (50.0%)
1 (50.0%)
0 (0.0%)
1 (50.0%)
0 (0.0%)
2 (100%)
0 (0.0%)
0 (0.0%)
10, 15, [12.5]
6, 17, [11.5]
1 (50.0%)
1 (50.0%)
2 (100.0%)
0 (0.0%)

Comparison
P-value
0.524 (W)
1.000 (F)
0.559 (F)

1.000 (F)

0.033 (W)
0.022 (W)
—–

∗
∗

—–

Table 2: Comparison results for a negative second CT of the head versus positive second CT of the head using only Patients
with a negative ﬁrst CT result. Numerical data is given as Mean (Standard Deviation), [Median]. Individual patient values
presented in Column two for Age, GCS and ISS, N=2. (W) = Wilcoxon Rank Sum Test, (F) = Fisher’s Exact Test. ∗ Statistically
Signiﬁcant, P < 0.05. ∗ ∗ Head struck with hard object.

went a second head CT scan. Of those 420 encounters with a repeat head CT scan, 418 encounters had a negative second CT head
(99.5%) and 2 had a positive second CT head scans (0.5%). 95% CI
[0.06%, 1.7%].
Of the 19 total patient encounters with a positive initial CT scan
of the head (3.8%), 15 (78.9%) had a positive repeat CT head scan.
2 patient encounters (10.5%) had repeat CT head scans which were
negative for acute intracranial hemorrhage. 2 of the 19 patient encounters (10.5%) did not have a repeat CT head imaging.
Looking at the results of the initial CT scan imaging, we found
that the positive initial CT scan encounters have a signiﬁcantly
higher median ISS than the negative ﬁrst CT scan encounters (6.0
vs 1.0, p<0.001). We also found that the ﬁrst positive CT scans for
intracranial hemorrhage were more likely, but did not reach statistical signiﬁcance, to involve female patients when compared to
patients with an initial negative CT scan (78.9% female vs 54.7%,
p=0.058). The type of DOAC, presenting GCS and the type of
trauma mechanism did not have a statistically signiﬁcant impact
on the likelihood of a positive ﬁrst CT scan. Table 1.
Looking at the second CT scan results, we only had two patients (0.5%) who had a new positive ﬁnding on their second head
CT scan after having a negative initial CT scan which limits the
statistical power to make clinical guidelines and conclusions. We
found that those patients had statistically signiﬁcant higher median ISS than those with a negative second CT scan (11.5 vs 1.0,
p=0.022) with actual ISS of 6 and 17 for those two patients. We
also found that those two patients had lower median GCS compared to those who did not have a new intracranial hemorrhage
(12.5 vs 15, p=0.033) but with actual values of 10 and 15 making
it hard to draw clinically signiﬁcant conclusions due to low statistical power. There was no statistically signiﬁcant relationship between sex, type of DOAC (Apixaban, Rivaroxaban, or Dabigatran),
and mechanism of injury with the likelihood of developing a positive repeat CT scan after an initial negative scan. (see Table 2).

in patients on DOACs. Of these studies, the results regarding the
necessity of repeat imaging to assess for delayed intracranial hemorrhage are mixed [9–12]. Furthermore, the sample sizes of patients on DOACs in these studies are limited compared to the sample size used in this study. Given the rising use of these medications in clinical practice for treatment of atrial ﬁbrillation and venous thromboembolism, particularly in geriatric patients who are
at higher risk of falls, this data is important in evaluating the risks
and beneﬁts of their use and help in the management guidelines
after head trauma. Admitting all head trauma patients on DOACs
to perform a routine repeat head CT scan does increase healthcare
costs and resource utilization with a potential increase in hospital acquired patient related adverse events. Presently, there is data
to suggest that foregoing repeat CT head imaging following a normal initial CT head in patients on aspirin, clopidogrel, and vitamin K antagonists with therapeutic INR may be reasonable due
to low rates of delayed intracranial hemorrhage [9,13–17]. Furthermore, repeat CT head imaging in patients who developed delayed
intracranial hemorrhage did not signiﬁcantly change management,
regardless of the type of antithrombotic therapy [18].
This study detected an overall incidence of 3.81% of ICH on initial head CT for conﬁrmed or suspected blunt head trauma patients
on DOACs. This comparable to rates cited in other studies. Rates
as low as 2% has been reported in patients on anticoagulant therapy by Campiglio, et al. [19]. Rates of ICH as high as 10.8% was
reported in patients on anticoagulation by Nishijima et al, though
interestingly, this study also did not identify anticoagulant therapy
as a risk factor for ICH when compared to a rate of 9.1% in patients not on anticoagulant or antiplatelet therapy [20]. Our study
detected an incidence of 0.47% (N = 2) for new delayed ICH after
an initial negative CT scan. This is lower than previously reported
rates in patients on DOACs with head trauma with smaller sample sizes [10,19,21]. Baramparas reported a rate of 0.8% in patients
on DOACs, while Cohan et al. reported a rate of 2.1% in patients
[21]. Campiglio et. al reported a rate of 1.4%, though it should be
noted that this study population was inclusive of patients on warfarin and low molecular weight heparin [19]. There is some data to
suggest that the risk of ICH in head trauma patients on DOACs is
equal or lower than in patients on vitamin K antagonists [10,22,23].
Of note, the two patients in our study with new delayed ICH
on the second CT scan did not require any neurosurgical interven-

Discussion
This study evaluates the rate of initial and delayed intracranial
hemorrhage in patients on DOACs after conﬁrmed or suspected
blunt head trauma. Presently, there are a limited number of studies
that assess the risk of delayed intracranial hemorrhage exclusively
3
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tion and both were discharged. These ﬁndings support our hypothesis and suggest that routine use of repeat CT head imaging after a negative initial CT in neurologically stable patients on DOACs
with low mechanism blunt head trauma did not confer any signiﬁcant clinical beneﬁts and will result in unnecessary costs and
over-utilization of healthcare resources.
In a recent study by Chenoweth et al., 2 out of 3 patients with
blunt head trauma developed a delayed intracranial hemorrhage 35 days following the initial insult [7]. Thus, it is also possible that
repeat head imaging within 24 hours may not be the most reliable
method to detect patients with delayed intracranial hemorrhages,
however, they are most likely minor [24].
Notably, patients who developed delayed intracranial hemorrhage in this study presented with a statistically signiﬁcant lower
GCS (10 and 15) and higher ISS (6 and 17) than in patients with
two negative CT head scans but with limited statistical power due
to a very small group size, N=2. This ﬁnding poses the question of
what risk factors may confer a higher risk of developing intracranial hemorrhage within the population of patients taking DOACs
that will guide us in selecting higher risk patient for observation
and/or repeat imaging. Cocca, et al. found a substantially higher
incidence of delayed intracranial hemorrhage of 20.8% in geriatric
patients over the age of 64 taking DOACs, of which 72% of patients experienced loss of consciousness [25]. These results highlight that age and loss of consciousness as possible factors that
may identify patients who would beneﬁt from repeat imaging. Another recent study done in Korea identiﬁed elderly age, associated
craniofacial fracture, neck injury, diabetes mellitus, and hypertension as risk factors for delayed intracranial hemorrhage [26]. Additional research in patients with delayed intracranial hemorrhage
is needed to determine what such risk factors are and their utility in medical decision making. Such factors such as age, loss of
consciousness, time from last medication dose, amnesia to event,
and medical comorbidities may be beneﬁcial to establish clearer
guidelines.
It’s important to note that 15.5% of our patients presented with
more than one fall during the study time period revealing a significant repeat fall risk in these patients. For that reason, our hospital refers all fall patients over 65 year of age to a “Stand Steady”
physical therapy program. This intervention is designed to identify
patients who are at high risk for falls and provide assistance and
interventions that could reduce the risk of future falls.
We believe that only select patients on DOACs might still
beneﬁt from an admission and observation following blunt head
trauma. High risk presentation criteria include higher ISS, lower
GCS or the presence of other injuries requiring an admission. Such
patients within this subgroup may require repeat imaging depending on their clinical and neurological status. Some have also suggested that admission with close monitoring of neurological status
is as effective as repeat CT head imaging [6].
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